-
Avatrombopag
- names:
Avatrombopag
- CAS号:
570406-98-3
MDL Number: - MF(分子式): C29H34Cl2N6O3S2 MW(分子量): 649.65
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM004642-10mg | 10mg | 97.81% | ¥ 6750.00 | ¥ 6750.00 | 2-3天 | ¥ 0.00 | ||
| YZM004642-5mg | 5mg | 97.81% | ¥ 4550.00 | ¥ 4550.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | Avatrombopag |
| CAS号 | 570406-98-3 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C29H34Cl2N6O3S2 |
| 分子量 Molecular Weight | 649.65 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度≥ 32 mg/mL(49.26 mM)*"≥" means soluble可溶, but saturation unknown溶解度未知. |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
| 产品说明 | |
| Introduction | Avatrombopag (E5501; AKR01; YM477) is an orallyctivethrombopoietin (TPO) receptoragonist with anEC50value of 3.3 nM and may be useful in the treatment of patients with thrombocytopenia. |
| Application1 | |
| Application2 | |
| Application3 |
Avatrombopag (E5501; AKR-501; YM477) 是一种有效的口服活性TPO受体激动剂,其EC50值为 3.3 nM,可用于治疗血小板减少症。Avatrombopag (E5501; AKR-501; YM477) is an orally-activethrombopoietin (TPO) receptoragonist with anEC50value of 3.3 nM and may be useful in the treatment of patients with thrombocytopenia[1].
【1】.Fukushima-Shintani M, et al. AKR-501 (YM477) a novel orally-active thrombopoietin receptor agonist. Eur J Haematol. 2009 Apr;82(4):247-54.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


